In addition, an investigation between the interaction of HLA-DRB1*15 and ETS was carried out, showing that carriage of this genotype – which was observed in 41.9% of the MS cohort – without ETS exposure did not increase the risk of developing MS. The gene discussed is HLA-DRB1; the disease is myeloid sarcoma.